蛋白17和原1型基因:食道癌分子标记物的发现和评估
Huiwen Pan1,2, Jie Hong2, Aizhong Shao2
1School of Food and Biological Engineering, Jiangsu University, Zhenjiang, China.
The clinical respiratory journal
|July 9, 2024
概括
在患有糖尿病的食道状细胞癌 (ESCC) 患者中发现了素17 (KRT17) 和原蛋白I型α1链 (COL1A1) 的升高水平. 这些基因有潜力成为ESCC的诊断生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 食道状细胞癌 (ESCC) 是一个重要的全球健康问题.
- 了解病因因素和确定ESCC可靠的生物标志物对于早期诊断和改善患者结果至关重要.
- 糖尿病与ESCC风险和进展之间的关联需要进一步调查.
研究的目的:
- 通过分析基因表达模式,探索食道状细胞癌 (ESCC) 的病因因素.
- 调查素17 (KRT17) 和 I型原α1链 (COL1A1) 的表达与ESCC患者,特别是糖尿病患者的临床参数之间的相关性.
- 评估KRT17和COL1A1作为ESCC诊断生物标志物的潜力.
主要方法:
- 对180对ESCC组织进行了转录组测序.
- 使用奇平方测试和相关性分析来评估基因表达与临床因素之间的关系.
- 使用定量实时PCR (qRT-PCR) 验证基因表达水平.
主要成果:
- 与对照组相比,糖尿病患者的ESCC组织中KRT17和COL1A1的相对表达水平显著更高.
- KRT17表达与血糖水平和瘤大小相关.
- COL1A1表达与年龄和血糖水平相关.
- qRT-PCR在ESCC中证实了KRT17和COL1A1的高表达 (p <0.05).
- 在KRT17和COL1A1的联合检测中,ESCC的阳性检测率达到了90.6%,ROC曲线显示出强大的诊断能力.
结论:
- 在ESCC中,KRT17和COL1A1显著上调,特别是在糖尿病的背景下.
- 这些基因与关键的临床参数 (如血糖,瘤大小和年龄) 有关.
- 对KRT17和COL1A1的综合分析表明,它们作为诊断ESCC的敏感和特定生物标志物具有相当大的潜力.
相关概念视频
03:18Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...